{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:46:18Z","timestamp":1784119578087,"version":"3.55.0"},"reference-count":26,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"DOI":"10.1136\/bjophthalmol-2016-308375","type":"journal-article","created":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T13:22:53Z","timestamp":1465996973000},"page":"bjophthalmol-2016-308375","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Treatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone"],"prefix":"10.1136","author":[{"given":"B","family":"Mueller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D J","family":"Salchow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Waffenschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Joussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Schmalisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ch","family":"Czernik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ch","family":"B\u00fchrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K U","family":"Schunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H J","family":"Girschick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Winterhalter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,6,14]]},"reference":[{"issue":"1","key":"key-10.1136\/bjophthalmol-2016-308375-1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr Res"},{"key":"key-10.1136\/bjophthalmol-2016-308375-2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF02482615","article-title":"Results of U.S. randomized clinical trial of cryotherapy for ROP (CRYO-ROP)","volume":"74","author":"Palmer","year":"1990","journal-title":"Doc Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308375-3","first-page":"233","article-title":"Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial","volume":"102","author":"Good","year":"2004","journal-title":"Trans Am Ophthalmol Soc"},{"key":"key-10.1136\/bjophthalmol-2016-308375-4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2016-308375-5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ophtha.2014.07.050","article-title":"Pathophysiology and mechanisms of severe retinopathy of prematurity","volume":"122","author":"Hartnett","year":"2015","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-308375-6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jaapos.2013.12.009","article-title":"Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy","volume":"18","author":"Henaine-Berra","year":"2014","journal-title":"J AAPOS"},{"key":"key-10.1136\/bjophthalmol-2016-308375-7","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","article-title":"Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial","volume":"132","author":"Geloneck","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308375-8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archophthalmol.2010.72","article-title":"Final visual acuity results in the early treatment for retinopathy of prematurity study","volume":"128","author":"Good","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308375-9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2011.07.005","article-title":"Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity","volume":"153","author":"Sato","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308375-10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The International Classification of Retinopathy of Prematurity Revisited","volume":"123","author":"Prematurity* AICftCoRo","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308375-11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-2008-1027168","article-title":"Guidelines for ophthalmological screening of premature infants in Germany","volume":"225","author":"Jandeck","year":"2008","journal-title":"Klin Monbl Augenheilkd"},{"key":"key-10.1136\/bjophthalmol-2016-308375-12","first-page":"1702","article-title":"Acuity card assessment of visual function in the cryotherapy for retinopathy of prematurity trial","volume":"31","author":"Dobson","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-308375-13","first-page":"2082","article-title":"Development of grating acuity in infants with regressed stage 3 retinopathy of prematurity","volume":"31","author":"Luna","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-308375-14","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/j.1651-2227.2011.02445.x","article-title":"On safety, pharmacokinetics and dosage of bevacizumab in ROP treatment\u2014a review","volume":"100","author":"H\u00e5rd","year":"2011","journal-title":"Acta Paediatr"},{"key":"key-10.1136\/bjophthalmol-2016-308375-15","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ophtha.2014.12.017","article-title":"Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: a 5-year retrospective analysis","volume":"122","author":"Hwang","year":"2015","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-308375-16","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archophthalmol.2012.592","article-title":"Reactivation of retinopathy of prematurity after bevacizumab injection","volume":"130","author":"Hu","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308375-17","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1242\/dev.125.9.1591","article-title":"A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF","volume":"125","author":"Benjamin","year":"1998","journal-title":"Development"},{"key":"key-10.1136\/bjophthalmol-2016-308375-18","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.ophtha.2014.05.015","article-title":"Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings","volume":"121","author":"Lepore","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-308375-19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/eye.2014.70","article-title":"Familial exudative vitreoretinopathy and related retinopathies","volume":"29","author":"Gilmour","year":"2015","journal-title":"Eye (Lond)"},{"key":"key-10.1136\/bjophthalmol-2016-308375-20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.survophthal.2013.03.007","article-title":"Current management of Coats disease","volume":"59","author":"Sigler","year":"2014","journal-title":"Surv Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308375-21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1423-0127-17-69","article-title":"Genetic susceptibility to advanced retinopathy of prematurity (ROP)","volume":"17","author":"Shastry","year":"2010","journal-title":"J Biomed Sci"},{"key":"key-10.1136\/bjophthalmol-2016-308375-22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3928\/23258160-20151214-02","article-title":"Retinopathy of prematurity versus familial exudative vitreoretinopathy: report on clinical and angiographic findings","volume":"47","author":"John","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"key-10.1136\/bjophthalmol-2016-308375-23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3928\/23258160-20160229-12","article-title":"Very late reactivation of retinopathy of prematurity after monotherapy with intravitreal bevacizumab","volume":"47","author":"Snyder","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"key-10.1136\/bjophthalmol-2016-308375-24","first-page":"1263","article-title":"Ocular alignment and refraction in preterm children at 1 and 6 years old","volume":"8","author":"Al Oum","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308375-25","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0161-6420(98)97036-1","article-title":"Prevalence of myopia between 3 months and 5 1\/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group","volume":"105","author":"Quinn","year":"1998","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-308375-26","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.ophtha.2005.03.025","article-title":"Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity","volume":"112","author":"Davitt","year":"2005","journal-title":"Ophthalmology"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2016-308375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T18:57:42Z","timestamp":1656701862000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2016-308375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,14]]},"references-count":26,"alternative-id":["10.1136\/bjophthalmol-2016-308375"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2016-308375","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,14]]}}}